Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.236SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21797.8South Korea
GK.11ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-21800.5Japan
XBB.1.38ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-21800.5Japan
JB.1NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-21820.2US
GJ.1.2.3NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-21820.2US
AY.49 (Delta)NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-21820.2US
B.1.309NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-21820.2US
FY.4.1.2NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-21820.2US
KW.1.1NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-21820.2US
CH.1.1.32NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-21820.8US
B.52NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-21820.8US
XBB.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-21845.5Germany
XBB.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-21858.4China
B.1.1.192NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.39.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
ME.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LE.1.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XDR.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.49.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.5.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HV.1.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.16.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.15.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GK.1.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JD.1.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.441NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.509NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.293NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.225NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.637NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.39 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.26 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.103 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.3 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.18.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
MB.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LE.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LF.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
MD.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LP.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.29.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.2.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.24.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.18.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LU.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.40NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
MG.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used